0 Canadian Stock Exchange News - February 27, 2020Bolt Metals Corp. CEO Shares Rebranding Strategy in Exclusive NetworkNewsWire Broadcast NEW YORK, Feb. 27, 2020 (GLOBE NEWSWIRE) — via NetworkNewsAudio – Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE), formerly Pacific Rim Cobalt [...]Read More
0 NASDAQ Companies - February 27, 2020Manhattan Bridge Capital, Inc. Announces the Buyback of its Common SharesGREAT NECK, N.Y., Feb. 27, 2020 (GLOBE NEWSWIRE) — Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) announced that its Board of […]Read More
0 NASDAQ Companies - February 27, 2020RigNet Announces Fourth Quarter and Full Year 2019 Earnings Release Date and Earnings Call InformationHOUSTON, Feb. 27, 2020 (GLOBE NEWSWIRE) — RigNet, Inc. (NASDAQ: RNET) today announced that it will release its fourth quarter […]Read More
0 NASDAQ Companies - February 27, 2020Catalyst Pharmaceuticals Announces Support of Rare Disease Day 2020CORAL GABLES, Fla., Feb. 27, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused […]Read More
0 NASDAQ Companies - February 27, 2020Digirad Corporation to Release 2019 Fourth Quarter and Year End Financial Results on March 6, 2020SUWANEE, Ga., Feb. 27, 2020 (GLOBE NEWSWIRE) — Digirad Corporation (Nasdaq: DRAD; DRADP) (“Digirad” or the “Company”) will release its financial […]Read More
0 NASDAQ Companies - February 27, 2020aTyr Pharma Announces Publication in the Journal Cellular and Molecular ImmunologyPaper highlights the essential role that histidyl tRNA synthetase (HARS) plays in immune responses in a broad range of inflammatory […]Read More
0 NASDAQ Companies - February 27, 2020II-VI Incorporated Offers a Portfolio of Integrated Circuits for High-Speed Transceivers in Datacenters and 5G Optical InfrastructurePITTSBURGH, Feb. 27, 2020 (GLOBE NEWSWIRE) — II‐VI Incorporated (Nasdaq:IIVI), a global leader in optical communications components and subsystems, today […]Read More
0 NASDAQ Companies - February 27, 2020Ultragenyx and Kyowa Kirin Announce FDA Acceptance and Priority Review Designation of Supplemental Biologics License Application for Crysvita® (burosumab) for Tumor-Induced Osteomalacia (TIO)NOVATO, Calif. and TOKYO, Feb. 27, 2020 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the […]Read More
0 NASDAQ Companies - February 27, 2020Infinera Withdraws Participation from OFC 2020SUNNYVALE, Calif., Feb. 27, 2020 (GLOBE NEWSWIRE) — Infinera (NASDAQ: INFN) today announced its decision to withdraw from participation in […]Read More
0 TSX Venture News - February 27, 2020Kutcho Copper Receives $1.46 Million METC RefundVANCOUVER, British Columbia, Feb. 27, 2020 (GLOBE NEWSWIRE) — Kutcho Copper Corp. (TSXV: KC) (OTC: KCCFF) (“Kutcho Copper” or the […]Read More